HanchorBio Inc. (TPEX:7827)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
78.80
-2.20 (-2.72%)
Last updated: Dec 5, 2025, 11:19 AM CST
15.88%
Market Cap 10.18B
Revenue (ttm) 312.22M
Net Income (ttm) -497.62M
Shares Out 130.01M
EPS (ttm) -4.43
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 649,748
Average Volume 437,611
Open 80.50
Previous Close 81.00
Day's Range 76.00 - 82.20
52-Week Range 41.80 - 95.20
Beta n/a
RSI 63.50
Earnings Date Nov 28, 2025

About HanchorBio

HanchorBio Inc. operates as a biotechnology company that develops biologics for cancer patients. The company offers FBDB platform to develop biological medicines. The company also engages in novel target research and evaluation, development of in vitro and in vivo models for evaluating the bioactivities of anti-cancer drugs, and development of proteins. HanchorBio Inc. was founded in 2020 and is based in Taipei, Taiwan with an additional office in Shanghai, China. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2020
Country Cayman Islands
Stock Exchange Taipei Exchange
Ticker Symbol 7827
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.